Sources Eli Lilly TRIUMPH-4 Phase 3 trial results (December 2025) Eli Lilly TRIUMPH-1 Phase 3 topline results (May 21, 2026) Jastreboff AM, et al
The activated AMPK pathway enhances brown tissue activation via transcriptional regulators of genes involved in brown tissue development (PR domain containing 16, peroxisome proliferator-activated receptor , peroxisome proliferator-activated receptor coactivator 1)
Slow, steady weight loss helps
FOR SELF-FUNDED PLANS WITH DIFFERENT FORMULARIES If Your Plan Excludes Wegovy If Your Plan Excludes Wegovy Some self-funded employer plans have customized formularies that may not include Wegovy
Clinical trials show adults taking the 14 mg daily dose lose an average of 8 to 9 pounds over six months, while non-diabetic users may see 5 to 10% body weight reduction over a full year
Daisy and Tom do not exist